EDGAR Filing Documents for 0000950170-22-001781

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0000950170-22-001781

Filing Date

2022-02-23

Accepted

2022-02-23 16:12:10

Documents

101

Period of Report

2021-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	gbt-20211231.htm iXBRL	10-K	4509453
2	EX-10.7	gbt-ex10_7.htm	EX-10.7	83270
3	EX-10.12	gbt-ex10_12.htm	EX-10.12	71240
4	EX-10.16	gbt-ex10_16.htm	EX-10.16	32507
5	EX-10.21	gbt-ex10_21.htm	EX-10.21	1535686
6	EX-21.1	gbt-ex21_1.htm	EX-21.1	1448
7	EX-23.1	gbt-ex23_1.htm	EX-23.1	4127
8	EX-31.1	gbt-ex31_1.htm	EX-31.1	23000
9	EX-31.2	gbt-ex31_2.htm	EX-31.2	22966
10	EX-32.1	gbt-ex32_1.htm	EX-32.1	14488
11	EX-32.2	gbt-ex32_2.htm	EX-32.2	14556
12	GRAPHIC	img110523152_0.jpg	GRAPHIC	67530
13	GRAPHIC	img110523152_1.jpg	GRAPHIC	74612
14	GRAPHIC	img110523152_2.jpg	GRAPHIC	19552
15	GRAPHIC	img110523152_3.jpg	GRAPHIC	62896
16	GRAPHIC	img110523152_4.jpg	GRAPHIC	39190
	Complete submission text file	0000950170-22-001781.txt		17391520

Data Files

Seq	Description	Document	Type	Size
17	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	gbt-20211231_def.xml	EX-101.DEF	281794
18	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	gbt-20211231_pre.xml	EX-101.PRE	502372
19	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	gbt-20211231.xsd	EX-101.SCH	68254
20	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	gbt-20211231_lab.xml	EX-101.LAB	634403
21	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	gbt-20211231_cal.xml	EX-101.CAL	64048
95	EXTRACTED XBRL INSTANCE DOCUMENT	gbt-20211231_htm.xml	XML	2952115

Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080

Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700

Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)